Hospital admissions per patient, by modality figure 5

Slides:



Advertisements
Similar presentations
When Using DOPPS Slides. DOPPS Slide Use Guidelines.
Advertisements

Chapter 4: Hospitalization 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 3: Clinical Indicators and Preventive Care 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 2: Healthy People A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 5: Mortality 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Gerard Dou, The Dropsical Woman, 1663, Louvre, Paris Peer Report: Dialysis Care & Outcomes in the U.S., 2014 Executive Summary.
Infections in the dialysis population: A major communicable disease issue! Allan J. Collins, MD, FACP Professor of Medicine University of Minnesota Director,
USRDS 1998 II , ,515 74,116 51,762 Period Prev. Point Prev. Incidence Deaths LFU** Counts (1000s) Year *Preliminary **Lost-to-Followup Reported.
UKRR – HES linkage James Fotheringham Sheffield Kidney Institute.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 9: Cardiovascular Disease in Patients With ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 14: End-of-life Care for Patients with End-Stage Renal Disease:
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 10: Dialysis Providers.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 5: Hospitalization.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 2: Healthy People 2020.
ESRD Prognoses James Heaf. This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used.
USRDS USRDS 2002 adr Period prevalent ESRD patient, deaths, & ESRD expenditures figure 12.1.
USRDS 2000 ADR USRDS Hepatitis B vaccine & antibody among patients & unit staff figure 9.1, dialysis patients, 1997, by network.
USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
Primary Cause of Kidney Failure in new ESRD patients at initiation, by ethnicity figure 2.1, combined.
2016 Annual Data Report, Vol 2, ESRD, Ch 5
2016 Annual Data Report, Vol 2, ESRD, Ch 8
Figure 3.1 ESRD clinical indicators, CROWNWeb data, December 2015
Figure 9.1 Causes of death in ESRD patients,
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Healthy People 2010 targets & levels achieved in 2000 figure hp.1
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
First-year death rates by modality figure 8
Odd ratio of developing kidney failure figure 1
Patient populations by study group figure 10
Mortality rates in incident ESRD patients figure 9
Volume 2: End-Stage Renal Disease
Chapter 8: Cardiovascular Disease in Patients with ESRD
2017 Annual Data Report Healthy People 2020.
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Chapter 12: End-of-life Care for Patients with ESRD:
Chapter 7: ESRD among Children, Adolescents, and Young Adults
December 31st point prevalent counts by modality figure 3.1
UK Renal Registry 18th Annual Report
Figure 2.1 First-year hospital admission rates among incident dialysis patients, by annual & monthly cohorts Patients aged 18 years or older. Peer Report Dialysis.
2016 Annual Data Report, Vol 2, ESRD, Ch 4
Volume 1: Chronic Kidney Disease Chapter 5: Acute Kidney Injury
Volume 1: Chronic Kidney Disease Chapter 3: Morbidity and Mortality
Chapter 2: Clinical Indicators and Preventive Care
2016 Annual Data Report, Vol 2, ESRD, Ch 14
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Chapter 6: CKD among Children and Adolescents
2016 Annual Data Report, Vol 1, CKD, Ch 3
Hemoglobin, EPO, & Iron dose figure 4
2018 Annual Data Report Volume 3: Healthy People 2020
2018 Annual Data Report Volume 1: Chronic Kidney Disease
Chapter 3: Morbidity and Mortality
Volume 2: End-Stage Renal Disease
Volume 2: End-Stage Renal Disease
Volume 64, Pages S3-S12 (December 2003)
Chapter 8: Cardiovascular Disease in Patients with ESRD
Chapter 12: End-of-life Care for Patients with ESRD:
Fig 6.1 Frequency of ischaemic heart disease in incident patients
Type of vascular access and mortality in U.S. hemodialysis patients
UK Renal Registry 14th Annual Report
New ESRD Patients and Main Sources
Cause Specific Death Rates for All Dialysis Patients
Reported ESRD Period and Point Prevalence,
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
The Use of Vaccines in Adult Patients With Renal Disease
Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley 
Worldwide incidence of ESRD figure 12.1, per million population
Mary B. Leonard, Lynn A. Donaldson, Martin Ho, Denis F. Geary 
Figure 9.1.a Causes of death in ESRD patients,
Presentation transcript:

Hospital admissions per patient, by modality figure 5 Hospital admissions per patient, by modality figure 5.1, prevalent patients USRDS

Hospital days per admission & per patient year at risk, by modality figure 5.2, prevalent patients USRDS

Hospital admissions per patient figure 5 Hospital admissions per patient figure 5.3, prevalent ESRD patients, 1998 Hospital admissions per patient USRDS

Hospital days per admission figure 5.4, prevalent ESRD patients, 1998 USRDS

Hospital days per year at risk figure 5 Hospital days per year at risk figure 5.5, prevalent ESRD patients, 1998 Hospital days per year at risk USRDS

Hospital days per year at risk figure 5 Hospital days per year at risk figure 5.6, prevalent hemodialysis patients, 1998 Hospital days per year at risk USRDS

Hospital days per year at risk figure 5 Hospital days per year at risk figure 5.7, prevalent peritoneal dialysis patients, 1998 Hospital days per year at risk USRDS

Hospital days per year at risk figure 5 Hospital days per year at risk figure 5.8, prevalent transplant patients, 1998 Hospital days per year at risk USRDS

Hospital days per year at risk figure 5 Hospital days per year at risk figure 5.9, prevalent diabetic ESRD patients, 1998 Hospital days per year at risk USRDS

Hospital days per year at risk figure 5 Hospital days per year at risk figure 5.10, prevalent non-diabetic ESRD patients, 1998 Hospital days per year at risk USRDS

Hospital admissions by age group figure 5 Hospital admissions by age group figure 5.11, prevalent patients, 1996-1998 USRDS

Hospital admissions by race figure 5.12, prevalent patients, 1996-1998 USRDS

Hospital admissions by diabetic status figure 5 Hospital admissions by diabetic status figure 5.13, prevalent patients, 1996-1998 USRDS

Hospital days per year by age group& race: Hemodialysis figure 5 Hospital days per year by age group& race: Hemodialysis figure 5.14, prevalent patients, 1996-1998 USRDS

Hospital days per year by age group & race: Peritoneal dialysis figure 5.14, prevalent patients, 1996-1998 USRDS

Hospital days per year by age group& race: Transplant figure 5 Hospital days per year by age group& race: Transplant figure 5.14, prevalent patients, 1996-1998 USRDS

Hospital days per year by age group& race: All dialysis figure 5 Hospital days per year by age group& race: All dialysis figure 5.14, prevalent patients, 1996-1998 USRDS

Hospital days per year by age group & diabetic status: Diabetics figure 5.14, prevalent patients, 1996-1998 USRDS

Hospital days per year by age group & diabetic status: Non-diabetics figure 5.14, prevalent patients, 1996-1998 USRDS

Frequency of vascular access procedures, hemodialysis figure 5 Frequency of vascular access procedures, hemodialysis figure 5.15, prevalent hemodialysis patients, 1998 USRDS

Frequency of infection (overall), hemodialysis figure 5 Frequency of infection (overall), hemodialysis figure 5.15, prevalent hemodialysis patients, 1998 USRDS

Frequency of infection (vascular access), hemodialysis figure 5 Frequency of infection (vascular access), hemodialysis figure 5.15, prevalent hemodialysis patients, 1998 USRDS

Frequency of cardiovascular (overall) diagnoses, hemodialysis figure 5 Frequency of cardiovascular (overall) diagnoses, hemodialysis figure 5.15, prevalent hemodialysis patients, 1998 USRDS

Frequency of heart catheterizations, hemodialysis figure 5 Frequency of heart catheterizations, hemodialysis figure 5.15, prevalent hemodialysis patients, 1998 USRDS

Frequency of amputations, hemodialysis figure 5 Frequency of amputations, hemodialysis figure 5.15, prevalent hemodialysis patients, 1998 USRDS

Frequency of catheter complications, peritoneal dialysis figure 5 Frequency of catheter complications, peritoneal dialysis figure 5.16, prevalent peritoneal dialysis patients, 1998 USRDS

Frequency of infection (overall), peritoneal dialysis figure 5 Frequency of infection (overall), peritoneal dialysis figure 5.16, prevalent peritoneal dialysis patients, 1998 USRDS

Frequency of infection (peritonitis) peritoneal dialysis figure 5 Frequency of infection (peritonitis) peritoneal dialysis figure 5.16, prevalent peritoneal dialysis patients, 1998 USRDS

Frequency of cardiovascular (overall) diagnoses, peritoneal dialysis figure 5.16, prevalent peritoneal dialysis patients, 1998 USRDS

Frequency of heart catheterizations, peritoneal dialysis figure 5 Frequency of heart catheterizations, peritoneal dialysis figure 5.16, prevalent peritoneal dialysis patients USRDS

Frequency of amputations, peritoneal dialysis figure 5 Frequency of amputations, peritoneal dialysis figure 5.16, prevalent peritoneal dialysis patients USRDS

Hospital days for cardiovascular & amputation procedures figure 5 Hospital days for cardiovascular & amputation procedures figure 5.17, prevalent dialysis patients, 1998 Asian N. Am. Black White Asian N. Am. Black White USRDS

Hospital days for heart catheterizations & revascularizations figure 5 Hospital days for heart catheterizations & revascularizations figure 5.18, prevalent dialysis patients, 1998 Asian N. Am. Black White Asian N. Am. Black White USRDS

Hospital days for access infections & complications figure 5 Hospital days for access infections & complications figure 5.19, prevalent dialysis patients, 1998 Asian N. Am. Black White Asian N. Am. Black White USRDS

Hospital admissions per patients figure 5 Hospital admissions per patients figure 5.20, incident & prevalent transplant patients USRDS

Development of new diagnoses figure 5 Development of new diagnoses figure 5.21, prevalent ESRD patients without a prior history of the diagnosis USRDS

Development of new diagnoses (cont. ) figure 5 Development of new diagnoses (cont.) figure 5.21, prevalent ESRD patients without a prior history of the diagnosis USRDS